How can pharma teams scale AI safely across channels? In this session, Ed Hart and Nicolas Barcza explore why strong Design ...

COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation ...

The NIRSE-GAL study, conducted in Galicia, Spain, is the first prospective real-world population study to evaluate the impact ...

Leading global healthcare services provider Uniphar announces a strategic merger between Uniphar | Clinical and BMclinical, reinforcing Uniphar | ...

We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.

The campaign repositions what is perceived as ‘normal’ in women’s health to support WOMEN | Bayer’s core message: ‘If it’s ...

Sanofi has announced positive results from its study of venglustat in in adults and children over 12 with neurological manifestations of type 3 Gaucher disease (GD3).

CagriSema improved weight loss and blood glucose control compared to semaglutide alone across all tested doses ...

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually ...

Approximately 70% of metastatic triple-negative breast cancer patients are ineligible for immunotherapy, creating an unmet ...

Union Chimique Belge (UCB) has announced the release of new positive data regarding Bimzelx (bimekizumab) in moderate to ...

Modern marketing is a hybrid craft, built on human judgement and empathy, strengthened by AI’s ability to work at scale and ...